| __timestamp | Rhythm Pharmaceuticals, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 13774000 |
| Thursday, January 1, 2015 | 3425000 | 22479000 |
| Friday, January 1, 2016 | 6311000 | 27388000 |
| Sunday, January 1, 2017 | 9518000 | 35610000 |
| Monday, January 1, 2018 | 28080000 | 49007000 |
| Tuesday, January 1, 2019 | 36550000 | 61139000 |
| Wednesday, January 1, 2020 | 46125000 | 68836000 |
| Friday, January 1, 2021 | 68486000 | 97592000 |
| Saturday, January 1, 2022 | 92032000 | 106903000 |
| Sunday, January 1, 2023 | 117532000 | 120998000 |
Unlocking the unknown
In the dynamic world of biotechnology, understanding financial trends is crucial. Rhythm Pharmaceuticals, Inc. and Vericel Corporation, two prominent players, have shown distinct patterns in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Rhythm Pharmaceuticals saw a staggering increase in SG&A expenses, growing nearly 97 times from 2014 to 2023. Meanwhile, Vericel Corporation's SG&A expenses rose by approximately 8.8 times during the same period. This growth reflects their strategic investments in operational expansion and market penetration. Notably, both companies reached their peak SG&A spending in 2023, with Vericel slightly ahead. These trends highlight the competitive nature of the biotech industry, where strategic financial management is key to sustaining growth and innovation.
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Rhythm Pharmaceuticals, Inc.
BeiGene, Ltd. vs Vericel Corporation: SG&A Expense Trends
Neurocrine Biosciences, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs Vericel Corporation
SG&A Efficiency Analysis: Comparing CRISPR Therapeutics AG and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Rhythm Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Vericel Corporation vs Merus N.V. Trends and Insights
SG&A Efficiency Analysis: Comparing Vericel Corporation and ImmunityBio, Inc.